|
|
Volumn 99, Issue 11, 2007, Pages 826-827
|
|
Serum proteomic classifier for predicting response to epidermal growth factor receptor inhibitor therapy: have we built a better mousetrap?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
PROTEIN KINASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
TUMOR MARKER;
BLOOD;
CLASSIFICATION;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MASS SPECTROMETRY;
NOTE;
PROGNOSIS;
PROTEOMICS;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
PROGNOSIS;
PROTEIN KINASE INHIBITORS;
PROTEOMICS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 34347381562
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djk221 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
